Form 4: HealthEquity Founder Gifts Shares for Estate Planning

Sentiment:

Insider Transaction Report


HealthEquity's Founder and Vice Chairman, Stephen Neeleman, reported a gift of 140,000 common shares to his spouse for estate planning purposes.

Summary

  • Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc. (HQY), reported a change in beneficial ownership.
  • On December 19, 2025, Neeleman gifted 140,000 shares of common stock to his spouse.
  • This transaction is described as a bona fide gift for estate planning purposes.
  • Following the transaction, Neeleman directly owns 111,535 shares of common stock.
  • Indirectly, 409,735 shares are held by the Stephen and Christine Neeleman Trust.
  • An additional 140,000 shares are beneficially owned by his spouse (acquired through this gift), for which Neeleman disclaims beneficial ownership.
  • 203,000 shares are held by Neeleman Family Holdings, LLC, with Neeleman disclaiming beneficial ownership except for his pecuniary interest.
  • Neeleman also holds stock options to buy 19,897 shares at $41.28 (expiring March 27, 2027), 14,228 shares at $61.72 (expiring March 27, 2028), and 15,337 shares at $73.61 (expiring March 26, 2029), all of which are immediately exercisable.

Sentiment

Score: 5

Explanation: A neutral event. The transaction is a personal estate planning gift by a founder, not indicative of company performance or a change in confidence in the company's future. The disclaimers of beneficial ownership are standard for such transactions.

Positives

  • The transaction reflects a key executive's long-term personal financial and estate planning, which can be a sign of stability in personal affairs.

Negatives

  • No direct negatives for the company's operational performance or financial health are indicated by this personal transaction.

Future Outlook

No future outlook or guidance is provided in this insider transaction report.

Management Comments

  • Transaction represents a bona fide gift to Reporting Person's spouse for estate planning purposes.
  • The Reporting Person disclaims beneficial ownership of these securities [held by spouse], and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  • The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

Industry Context

This filing reports a personal insider transaction and does not provide information directly related to broader industry trends or competitive landscape. It reflects the personal financial planning of a key executive.

Related Party Transactions

  • Gift of 140,000 common shares from Stephen Neeleman to his spouse for estate planning purposes.

Stakeholder Impact

  • Shareholders: Minimal direct impact. A founder's personal estate planning is generally not a material event for share price, though a reduction in direct holdings could be scrutinized if not for the clear 'gift' context.
  • Employees, Customers, Suppliers, Creditors: No direct impact is expected from this personal transaction.

Key Dates

DateDescription
12/19/2025Date of earliest transaction (gift of common stock)
12/23/2025Signature date of the reporting person
03/27/2027Expiration date for 19,897 stock options at $41.28
03/27/2028Expiration date for 14,228 stock options at $61.72
03/26/2029Expiration date for 15,337 stock options at $73.61

Recommendation

hold

The filing details a personal estate planning transaction by a key executive, Stephen Neeleman, involving a gift of shares to his spouse. This type of insider transaction is generally considered neutral and does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The existing investment thesis for HealthEquity (HQY) remains unchanged based on this filing.

Keywords

HealthEquity, HQY, Stephen Neeleman, Form 4, Insider Transaction, Beneficial Ownership, Stock Gift, Estate Planning, Common Stock, Stock Options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.